OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy

Korábbi kezelés

• Concurrent participation in another clinical trial on the same indication

Más betegség

• Any other malignancy within the last 5 years which has an impact on the prognosis of the patient
• Any other serious underlying medical, psychiatric, psychological, familial, or geographical condition, which in the judgment of the sponsor-project leader may interfere with the project or affect patient compliance

Egyéb

• ECOG ≥3
• Pregnant or lactating women

• Age ≥ 18 years
• Newly diagnosed EOC (adenocarcinoma of the ovary, peritoneum, and fallopian tube) and carcinosarcoma patients with a suspected FIGO Stage III and IV
• No immediate need of systemic or surgical treatment at time of and until 2 weeks after diagnosis
• Envisaged surgical candidate for interval debulking after 2 cycles of treatment
• Patients have adequate hematology, liver and kidney functions
• Willing and able to attend the visits, to understand the purpose of the trial and all trial-related procedures
• ECOG 0-2
• Written informed consent according to national legal and regulatory requirements prior to any project specific procedures